BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 31842256)

  • 21. Toll-like receptor 9 ligand D-type oligodeoxynucleotide D35 as a broad inhibitor for influenza A virus replication that is associated with suppression of neuraminidase activity.
    Yamada H; Nagase S; Takahashi K; Sakoda Y; Kida H; Okamoto S
    Antiviral Res; 2016 May; 129():81-92. PubMed ID: 26923882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A zanamivir dimer with prophylactic and enhanced therapeutic activity against influenza viruses.
    Tarbet EB; Hamilton S; Vollmer AH; Luttick A; Ng WC; Pryor M; Hurst BL; Crawford S; Smee DF; Tucker SP
    J Antimicrob Chemother; 2014 Aug; 69(8):2164-74. PubMed ID: 24777908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of acylguanidine oseltamivir carboxylate derivatives as potent neuraminidase inhibitors.
    Li Z; Meng Y; Xu S; Shen W; Meng Z; Wang Z; Ding G; Huang W; Xiao W; Xu J
    Bioorg Med Chem; 2017 May; 25(10):2772-2781. PubMed ID: 28385598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of novel 1,2,3-triazole oseltamivir derivatives as potent influenza neuraminidase inhibitors targeting the 430-cavity.
    Ju H; Xiu S; Ding X; Shang M; Jia R; Huang B; Zhan P; Liu X
    Eur J Med Chem; 2020 Feb; 187():111940. PubMed ID: 31835169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiviral activity of puerarin as potent inhibitor of influenza virus neuraminidase.
    Wang HX; Zeng MS; Ye Y; Liu JY; Xu PP
    Phytother Res; 2021 Jan; 35(1):324-336. PubMed ID: 32757226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuraminidase Activity and Resistance of 2009 Pandemic H1N1 Influenza Virus to Antiviral Activity in Bronchoalveolar Fluid.
    Ruangrung K; Suptawiwat O; Maneechotesuwan K; Boonarkart C; Chakritbudsabong W; Assawabhumi J; Bhattarakosol P; Uiprasertkul M; Puthavathana P; Wiriyarat W; Jongkaewwattana A; Auewarakul P
    J Virol; 2016 May; 90(9):4637-4646. PubMed ID: 26912622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiviral activity of furanocoumarins isolated from Angelica dahurica against influenza a viruses H1N1 and H9N2.
    Lee BW; Ha TKQ; Cho HM; An JP; Kim SK; Kim CS; Kim E; Oh WK
    J Ethnopharmacol; 2020 Sep; 259():112945. PubMed ID: 32389854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction of Neuraminidase Activity Exacerbates Disease in 2009 Pandemic Influenza Virus-Infected Mice.
    Ranadheera C; Hagan MW; Leung A; Collignon B; Cutts T; Theriault S; Embury-Hyatt C; Kobasa D
    J Virol; 2016 Nov; 90(21):9931-9941. PubMed ID: 27558428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity of enisamium, an isonicotinic acid derivative, against influenza viruses in differentiated normal human bronchial epithelial cells.
    Boltz D; Peng X; Muzzio M; Dash P; Thomas PG; Margitich V
    Antivir Chem Chemother; 2018; 26():2040206618811416. PubMed ID: 30466301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different neuraminidase inhibitor susceptibilities of human H1N1, H1N2, and H3N2 influenza A viruses isolated in Germany from 2001 to 2005/2006.
    Bauer K; Richter M; Wutzler P; Schmidtke M
    Antiviral Res; 2009 Apr; 82(1):34-41. PubMed ID: 19428593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of novel "Dual-site" binding oseltamivir derivatives as potent influenza virus neuraminidase inhibitors.
    Ai W; Zhang J; Zalloum WA; Jia R; Cherukupalli S; Ding X; Sun Z; Sun L; Jiang X; Ma X; Li Z; Wang D; Huang B; Zhan P; Liu X
    Eur J Med Chem; 2020 Apr; 191():112147. PubMed ID: 32092589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Replication inhibition activity of carbocycles related to oseltamivir on influenza A virus in vitro.
    Niikura M; Bance N; Mohan S; Mario Pinto B
    Antiviral Res; 2011 Jun; 90(3):160-3. PubMed ID: 21443905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emergence of H7N9 Influenza A Virus Resistant to Neuraminidase Inhibitors in Nonhuman Primates.
    Itoh Y; Shichinohe S; Nakayama M; Igarashi M; Ishii A; Ishigaki H; Ishida H; Kitagawa N; Sasamura T; Shiohara M; Doi M; Tsuchiya H; Nakamura S; Okamatsu M; Sakoda Y; Kida H; Ogasawara K
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4962-73. PubMed ID: 26055368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of Highly Potent Pinanamine-Based Inhibitors against Amantadine- and Oseltamivir-Resistant Influenza A Viruses.
    Zhao X; Li R; Zhou Y; Xiao M; Ma C; Yang Z; Zeng S; Du Q; Yang C; Jiang H; Hu Y; Wang K; Mok CKP; Sun P; Dong J; Cui W; Wang J; Tu Y; Yang Z; Hu W
    J Med Chem; 2018 Jun; 61(12):5187-5198. PubMed ID: 29799746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistance to Mutant Group 2 Influenza Virus Neuraminidases of an Oseltamivir-Zanamivir Hybrid Inhibitor.
    Wu Y; Gao F; Qi J; Bi Y; Fu L; Mohan S; Chen Y; Li X; Pinto BM; Vavricka CJ; Tien P; Gao GF
    J Virol; 2016 Dec; 90(23):10693-10700. PubMed ID: 27654293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo.
    Ives JA; Carr JA; Mendel DB; Tai CY; Lambkin R; Kelly L; Oxford JS; Hayden FG; Roberts NA
    Antiviral Res; 2002 Aug; 55(2):307-17. PubMed ID: 12103431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities.
    Smee DF; Huffman JH; Morrison AC; Barnard DL; Sidwell RW
    Antimicrob Agents Chemother; 2001 Mar; 45(3):743-8. PubMed ID: 11181354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of the H275Y and I223V Mutations in the Neuraminidase of the 2009 Pandemic Influenza Virus In Vitro and Evaluating Experimental Reproducibility.
    Paradis EG; Pinilla LT; Holder BP; Abed Y; Boivin G; Beauchemin CA
    PLoS One; 2015; 10(5):e0126115. PubMed ID: 25992792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of influenza virus replication by plant-derived isoquercetin.
    Kim Y; Narayanan S; Chang KO
    Antiviral Res; 2010 Nov; 88(2):227-35. PubMed ID: 20826184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of N-substituted oseltamivir derivatives as potent and selective inhibitors of H5N1 influenza neuraminidase.
    Xie Y; Xu D; Huang B; Ma X; Qi W; Shi F; Liu X; Zhang Y; Xu W
    J Med Chem; 2014 Oct; 57(20):8445-58. PubMed ID: 25255388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.